CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 114 enrolled
Drug / intervention
99mTc-methyl diphosphonate +9 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00375830
NCT00375830Phase 2Completed
CompareCT.gov

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Stanford University·interventional·Posted Sep 13, 2006·Updated Dec 12, 2023

In Brief

A Phase 2 clinical trial evaluating Bone scan, 99mTc-methyl diphosphonate, and 8 other interventions for Cancer. Completed, enrolled 114 participants across 1 site.

Detailed Summary

This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 13, 2006
Enrollment StartJan 1, 2006
Primary CompletionApr 17, 2017
Study CompletionMar 14, 2019
TodayJul 2, 2026
Enrollment to primary: 11.3 yearsPosted 19.8 years ago

Interventions

Bone scanprocedure

Scan to diagnose a number of bone conditions including cancer or metastasis

99mTc-methyl diphosphonatedrug

Radiolabel for bone scan procedures

Positron Emission Tomography (PET) scanprocedure

Scan to detect gamma rays emitted by a positron-emitting radioligand such as 18F

18F-Fludeoxyglucose (18F-FDG)drug

Radiolabel for positron emission tomography scan procedures

Computed Tomography (CT) scanprocedure

Scan to detect \& analyze X-rays

18F-Sodium Fluoride (18F-NaF)drug

Radiolabel for CT and PET scans, \& as a contrast agent for MRI scans.

Whole Body Magnetic Resonance Imaging (WB-MRI) scanprocedure

Whole Body Magnetic Resonance Imaging (WB-MRI) scan: Scan that uses strong magnetic fields \& radio waves to generate images of the organs in the body.

Gadopentetate dimegluminedrug

A gadolinium-based contrast agent for MRI

Gadofosvesetdrug

A gadolinium-based contrast agent for MRI

Gadobutroldrug

A gadolinium-based contrast agent for MRI